Ligand profile
CHEMBL3962740
Bioactivity hit from ChEMBL on a similar protein.
Bound to: Q8NG11
Identifiers
Database identifiers and provenance.
- Ligand ID
CHEMBL3962740- UniProt (similar protein)
P08962- pchembl
- 6.130 (~741.3 nM)
- Target protein
- Q8NG11
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 99.6
- −1 ≤ LogP ≤ 5 3.13
- MW ≤ 500 Da 362.4
- LogP ≤ 5 3.13
- H-bond donors ≤ 5 2
- H-bond acceptors ≤ 10 8
- Rotatable bonds ≤ 10 5
- TPSA ≤ 140 Ų 99.6
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
COc1ccc(Nc2nc(-c3ccc(N)nc3)cn3ccnc23)cc1OCCOc1ccc(Nc2nc(-c3ccc(N)nc3)cn3ccnc23)cc1OC
InChI=1S/C19H18N6O2/c1-26-15-5-4-13(9-16(15)27-2)23-18-19-21-7-8-25(19)11-14(24-18)12-3-6-17(20)22-10-12/h3-11H,1-2H3,(H2,20,22)(H,23,24)InChI=1S/C19H18N6O2/c1-26-15-5-4-13(9-16(15)27-2)23-18-19-21-7-8-25(19)11-14(24-18)12-3-6-17(20)22-10-12/h3-11H,1-2H3,(H2,20,22)(H,23,24)
UUGFFVXOVKEYMH-UHFFFAOYSA-NUUGFFVXOVKEYMH-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ domain
- Source
- ChEMBL
- Activity
- 312367.0
- Binding sites
- PF00335
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ChEMBL ChEMBL compound CHEMBL3962740 →
- UniProt UniProt P08962 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “CHEMBL3962740”) →
Other ligands for this protein
Quick navigation to other ligands bound to Q8NG11.
ChEMBL 19
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).